Grifols Diagnostic Solutions, Inc. manufactures and markets plasma medicines and medical tools. Its services include blood group genotyping testing, IRL serology testing, prenatal testing, biological drug monitoring tests, FH genetic testing and other genetic testing. The company is headquartered in Emeryville, CA.

AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden.

Inke Innovation (Xiamen) Technology Co., Ltd., established on 1989-12-14, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Medical equipment rental;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Special Equipment Repair;Sales of bio-based materials;Specialty Chemicals Sales(Free of Hazardous Chemicals);Biochemical product technology research and development;Engineering and Technology Research and Experimental Development;Natural science research and experimental development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class III Medical Devices;Class III medical device business;Production of Class II Medical Devices;Drug import and export;pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines);Pharmaceutical commissioned production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines);Import and export;Technology Import and Export;Import and export agency.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Bio-Rad Innovations SAS engages in the development and production of chemicals used in biochemical, pharmaceutical and other life science research applications. The company is headquartered in Paris, France.

Part of CSL Ltd., CSL Behring GmbH is a German company located in Marburg. The firm manufactures plasma protein bio therapeutics for the treatment of rare and major diseases. Michael Schröder, Lutz Guenter Bonacker and Craig Shelanskey are the current co-CEOs of the firm.

SyntheX created a novel cell-based, synthetic biology-driven drug selection platform, that allows for the efficient synthesis and identification of peptides and macrocycles that selectively disrupt intracellular protein-protein interactions of interest. Although the platform has broad application, the initial focus is on oncology. Targets are selected based on the concepts of synthetic lethality and oncogene addiction, with the first program focused on DNA damage repair and working through a novel cell death mechanism that was uncovered.

DIAGAST SAS operates as a blood matching company. Its products include QWALYS range, Erythrocytes Magnetized technology, manual range, PK 7300 ranges, pre-transfusion control, disposable plates and technical inserts. The company was founded in 1968 and is headquartered in Loos, France.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

QBD (QS IP) Ltd., a subsidiary of Quotient Ltd., is a British company that develops transfusion diagnostics products to hospitals and blood banks.

Gamma Biologicals, Inc., a subsidiary of WerfenLife SA, is a company headquartered in Houston, TX. The firm makes and markets a wide variety of specialized testing products known as in vitro diagnostic reagents.

Alba Bioscience Ltd. provides pharmaceutical biotechnology services. It manufactures and supplies vital products to hospitals, and blood services and healthcare companies in the United Kingdom and internationally. The company is headquartered in Penicuik, the United Kingdom.

BioArray Solutions Ltd. develops and manufactures products for transfusion and transplantation medicine. Its solutions proprietary technology platform combines semiconductor technology, micro particle chemistry, and molecular biology to bring unparalleled flexibility and performance to quantitative DNA and protein analysis. The company was founded in 1997 and is headquartered in Warren, NJ.

Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs. Their value chain extends from pre-clinical and clinical development to worldwide marketing and distribution. Biotest manufactures immunoglobulins, clotting factors and albumins which derive from human blood plasma. Biotest also develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus which are produced by recombinant technologies. Biotest currently employs more than 2,500 people worldwide. The most important raw material for their pharmaceuticals is human blood plasma, which they process into effective and highly purified drugs in one of their world leading fractionation facilities in Europe. These medications are used to treat life-threatening diseases such as blood coagulation disorders (haemophilia), severe infections and immune system disorders.

Meiji Co., Ltd. produces and sells milk, dairy, confectioneries, and food. Its products include cheese, ice cream, chocolate, infant formula, whey protein, beauty supplements, and yogurt. The company was founded on December 21, 1917 and is headquartered in Tokyo, Japan.

Glycobia, Inc. operates platform technologies to enable glycoengineering, the intentional manipulation of protein-associated sugars to alter inherent properties of proteins for research, industrial and therapeutic applications. It engages in developing glyco-engineered bacteria that are capable of attaching human or human-like sugars onto proteins. The firm provides technology for efficient production of authentic human glycoproteins in microbial cells for manufacturing and engineering of therapeutic proteins. The company was founded by Adam C. Fisher, Matthew P. DeLisa and Chang B. Hong and is headquartered in Ithaca, NY.

Kode Biotech Limited is a private New Zealand company established in 1996 to commercialise and license Kode™ Technology.Kode Biotech Ltd is the licensor of existing, and developer of new Kode™ Technology.Vision: Change the surface of biotechnologyMission: Ignite a revolution with Kode™ surface modification nanotechnology by enabling our partners to enhance existing and create next generation products with a technology to shape life.Kode Biotech is the holder and parent of a number of subsidiary companies that licenses Kode™ Technology for various sectors and uses.